Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials

Author： Beckham Thomas H   Elojeimy Saeed   Cheng Joseph C   Turner Lorianne S   Hoffman Stanley R   Norris James S   Liu Xiang  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.5, 2010-05, pp. : 529-539

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Angiogenesis in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 643-649

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-11 ,pp. : 650-665

Bentham Science Publishers

Access to resources Recommend Favorite

EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer

By  

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-12 ,pp. : 691-710

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor

By  

Current Cancer Drug Targets, Vol. 7, Iss. 7, 2007-01 ,pp. : 633-642

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the STAT Pathway in Head and Neck Cancer: Recent Advances and Future Prospects

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 637-651

Bentham Science Publishers

Access to resources Recommend Favorite